1 |
Shoop, W. L., Xiong, Y., Wiltsie, J., Woods, A., Guo, J., Pivnichny, J. V., Felcetto, T., Michael, B. F., Bansal, A., Cummings, R. T. Cunningham, B. R., Friedlander, A. M., Douglas, C. M., Patel, S. B., Wisniewski, D., Scapin, G., Salowe, S. P., Zaller, D. M., Chapman, K. T., Scolnick, E. M., Schmatz, D. M., Bartizal, K., MacCoss, M. and Hermes, J. D. (2005) Anthrax lethal factor inhibition. Proc. Natl. Acad. Sci. U.S.A. 102, 7958-7963.
DOI
ScienceOn
|
2 |
Peinado, J. R., Kacprzak, M. M., Leppla, S. H. and Lindberg, I. (2004) Cross-inhibition between furin and lethal factor inhibitors. Biochem. Bioph. Res. Co. 321, 601-605.
DOI
ScienceOn
|
3 |
Huber, M., Vor Dem, E. U., Grunow, R. and Bessler, W. G. (2005) Generation of mouse polyclonal and human monoclonal antibodies against Bacillus anthracis toxin. Drugs Exp. Clin. Res. 31, 35-43.
|
4 |
Mourez, M., Kane, R. S., Mogridge, J., Metallo, S., Deschatelets, P., Sellman, B. R., Whitesides, G. M. and Collier, R. J. (2001) Designing a polyvalent inhibitor of anthrax toxin. Nat. Biotechnol. 19, 958-961.
DOI
ScienceOn
|
5 |
Duesbery, N. S., Webb, C. P., Leppla, S. H., Gordon, V. M., Klimpel, K. R., Copeland, T. D., Ahn, N. G., Oskarsson, M. K., Fukasawa, K., Paull, K. D. and Vande Woude, G. F. (1998) Proteolytic inactivation of MAP kinase kinase by anthrax lethal factor. Science 280, 734-737.
DOI
|
6 |
Barrett, A. J., Rawlings, N. D. and Woessner, J. F. (2004) Introduction: metallopeptidases and their clans. in Handbook of proteolytic enzymes. Elsevier academic press, London, UK.
|
7 |
Turk, B. E., Wong, T. Y., Schwarzenbacher, R., Jarrell, E. T., Leppla, S. H., Collier, R. J., Liddington, R. C. and Cantley, L. C. (2004) The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nat. Struct. Mol. Biol. 11, 60-66.
DOI
ScienceOn
|
8 |
Panchal, R. G., Hermone, A. R., Nguyen, T. L., Wong, T.Y. Schmidt, J., Lane, D., McGrath, C., Turk, B. E., Burnett, J., Aman, M. J., Little, S., Sausville, E. A., Zaharevitz, D. W., Cantley, L. C., Liddington, R. C., Gussio, R. and Bavari, S. (2004) Identification of small molecule inhibitors of anthrax lethal factor. Nat. Struct. Mol. Biol. 11, 67-72.
DOI
ScienceOn
|
9 |
Copeland, R. (2000) Enzymes: a practical introduction to structure, mechanism and data analysis (second edition). John Wiley & Sons, Inc., New York, USA.
|
10 |
Frazier, A. A., Franks, T. J. and Galvin, J. R. (2006) Inhalational anthrax. J. Thorac. Imaging 21, 252-258.
DOI
ScienceOn
|
11 |
Janeway, Jr., C. A. and Medzhitov. R. (2002) Innate immune recognition. Annu. Rev. Immunol. 20, 197-216.
DOI
ScienceOn
|
12 |
Pannifer, A. D., Wong, T. Y., Schwarzenbacher, R., Renatus, M., Petosa, C., Bienkowska, J., Lacy, D. B., Collier, R., Park, S., Leppla, H., Hunna, P. and Liddington, R. C. (2001) Crystal structure of the anthrax lethal factor. Nature 414, 229-233.
DOI
ScienceOn
|
13 |
Hanna, P., Acosta, D. and Collier, R. J. (1993) On the role of macrophages in anthrax. Proc. Natl. Acad. Sci. 90, 10198-10201.
DOI
|
14 |
Duesberya, N. S. and Vande Woudeb, G. F. (1999) Anthrax toxins. Cell. Mol. Life Sci. 55, 1599-1609.
DOI
|
15 |
Tournier, J. N., Quesnel-Hellmann, A., Cleret, A. and Vidal, D. R. (2007) Contribution of toxins to the pathogenesis of inhalational anthrax. Cellular Microbiology 9, 555-565.
DOI
ScienceOn
|
16 |
Boyden, E. D. and Dietrich, W. F. (2006) Nalp 1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nature Genetics 38, 240-244.
DOI
ScienceOn
|
17 |
Schepetkin, I. A., Khlebnikov, A. I., Kirpotina, L. N. and Quinn, M. T. (2006) Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening. J. Med. Chem. 49, 5232-5244.
DOI
ScienceOn
|
18 |
Turk, B. E. (2008) Discovery and development of anthrax lethal factor metalloprotease inhibitor. Curr. Pharm. Biotechno. 9, 24-33.
DOI
ScienceOn
|